Compounds > fluorobenzenes
Page last updated: 2024-08-21

fluorobenzenes and Cardiac Diseases

fluorobenzenes has been researched along with Cardiac Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balligand, JL; Beauloye, C; Hamelet, J; Herijgers, P; Hermida, N; Hilfiker-Kleiner, D; Horman, S; Markl, A; Noppe, G; Van Assche, T; van Bilsen, M; Vanderper, A1
Campbell, SM; Godman, B; Gustafsson, LL; Pichetti, S; Sermet, C1
Citrome, L; Jackson, G1
Arendt, CJ; Eggert, CH; Ireland, JH; Williams, AW1
Peterson, J; Swerdlow, CD; Turlapaty, P1

Other Studies

5 other study(ies) available for fluorobenzenes and Cardiac Diseases

ArticleYear
HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
    Cardiovascular research, 2013, Jul-01, Volume: 99, Issue:1

    Topics: Actins; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Collagen Type I; Diastole; Disease Models, Animal; Enzyme Activation; Fibroblasts; Fibrosis; Fluorobenzenes; Heart Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leptin; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Procollagen; Pyrimidines; Rats; Receptors, LDL; Recovery of Function; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Time Factors; Transfection; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Remodeling

2013
Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.
    Applied health economics and health policy, 2013, Volume: 11, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atorvastatin; Diabetes Mellitus; Drug Prescriptions; Drugs, Generic; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; France; General Practitioners; Heart Diseases; Heptanoic Acids; Humans; Indoles; Lipid Metabolism Disorders; Male; Middle Aged; Models, Statistical; Practice Patterns, Physicians'; Pravastatin; Prescription Drugs; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides

2013
JUPITER: wake up and smell the coffee--the absolute and relative merits of statin use.
    International journal of clinical practice, 2009, Volume: 63, Issue:3

    Topics: C-Reactive Protein; Cholesterol, HDL; Clinical Trials as Topic; Female; Fluorobenzenes; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Risk; Rosuvastatin Calcium; Sulfonamides

2009
Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.
    Annals of internal medicine, 2005, Jun-07, Volume: 142, Issue:11

    Topics: Acute Kidney Injury; Female; Fenofibrate; Fluorobenzenes; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Middle Aged; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides

2005
Clinical electrophysiology of flestolol, a potent ultra short-acting beta blocker.
    American heart journal, 1986, Volume: 111, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrioventricular Node; Electrocardiography; Electrophysiology; Female; Fluorobenzenes; Heart Conduction System; Heart Diseases; Humans; Male; Middle Aged; Neural Conduction; Propanolamines; Reaction Time; Sinoatrial Node; Time Factors

1986